Myocardial infarction (MI) is the leading cause of death in industrialized countries. All the traditional risk factors for MI are responsible for approximately 50% of cases of MI cases. Attention therefore has recently focused on genetic variants that are not associated with conventional risk factors. One of them is the marker rs6922269, which has been suggested as a risk factor for development of MI in Western populations. We analyzed the relationship between rs6922269 variant on MTHFD1L gene and (i) risk of the acute coronary syndrome (ACS) in the Czech population and (ii) mortality in 7 years follow up. Rs6922269 (G>A) variant was analyzed (CR 99.3% for patients and 98.0% for controls) by PCR-RFLP in consecutively examined 1614 men and 503 women with ACS (age below 65 years) and in population-based controls--1191 men and 1368 women (aged up to 65 years). ANOVA and Chi square were used for statistical analysis. The genotype frequencies were almost identical (P=0.87) in the ACS patients and in controls and no differences were observed, if males (P=0.73) and females (P=0.93) were analysed separately. In addition, rs6922269 polymorphism was not associated with the classical risk factors (dyslipidemia, hypertension, obesity, smoking, diabetes) in control population. Cardiovascular mortality was significantly higher in males, carriers of the AA genotype (P<0.001, OR 2.52, 95% CI 1.40-4.55, for AA vs. +G). We conclude, that rs6922269 variant at MTHFD1L gene could be an important prognostic factor for cardiovascular mortality in patients after ACS.

Center for Experimental Medicine Institute for Clinical and Experimental Medicine Prague Czech Republic

Zobrazit více v PubMed

PLoS One. 2011;6(12):e29427 PubMed

Mol Biol Rep. 2014 Mar;41(3):1545-52 PubMed

Atherosclerosis. 2009 Jul;205(1):174-80 PubMed

J Thromb Thrombolysis. 2010 Jan;29(1):114-8 PubMed

BMC Med Genet. 2011 Sep 29;12:127 PubMed

Clin Chim Acta. 2010 Aug 5;411(15-16):1069-72 PubMed

PLoS One. 2009;4(5):e5472 PubMed

Nicotine Tob Res. 2012 Aug;14 (8):998-1002 PubMed

Exp Clin Cardiol. 2010 Fall;15(3):e52-6 PubMed

PLoS One. 2014 Mar 11;9(3):e89029 PubMed

Mol Biol Rep. 2014;41(4):2281-6 PubMed

Atherosclerosis. 2009 Mar;203(1):41-4 PubMed

N Engl J Med. 2007 Aug 2;357(5):443-53 PubMed

JAMA. 2010 Feb 17;303(7):648-56 PubMed

Ann Hum Genet. 2011 Jul;75(4):475-82 PubMed

Circ Cardiovasc Genet. 2011 Dec;4(6):661-72 PubMed

Eur Heart J. 2012 Feb;33(3):393-407 PubMed

Hum Genet. 2008 Dec;124(5):553-5 PubMed

Nat Genet. 2008 Feb;40(2):149-51 PubMed

Folia Biol (Praha). 2012;58(5):203-8 PubMed

Addiction. 2009 Sep;104(9):1439-40 PubMed

Hum Mol Genet. 2007 Jan 1;16(1):24-35 PubMed

The Relationship Between Genetic Variants at Loci 9p21, 6q25.1, and 2q36.3 and the Development of Cardiac Allograft Vasculopathy in Heart Transplant Patients

APOL1 polymorphisms are not influencing acute coronary syndrome risk in Czech males

Cholesterol associated genetic risk score and acute coronary syndrome in Czech males